APA

Baetz T., Eisenhauer E., Siu L., MacLean M., Doppler K., Walsh W., Fisher B., Khan A. Z., de Alwis D. P., Weitzman A., Brail L. H. & Moore M. (20070730). A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. : Investigational new drugs.

Chicago

Baetz Tara, Eisenhauer Elizabeth, Siu Lillian, MacLean Martha, Doppler Karen, Walsh Wendy, Fisher Bryn, Khan Azhar Z, de Alwis Dinesh P, Weitzman A, Brail Leslie H and Moore Malcolm. 20070730. A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. : Investigational new drugs.

Harvard

Baetz T., Eisenhauer E., Siu L., MacLean M., Doppler K., Walsh W., Fisher B., Khan A. Z., de Alwis D. P., Weitzman A., Brail L. H. and Moore M. (20070730). A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. : Investigational new drugs.

MLA

Baetz Tara, Eisenhauer Elizabeth, Siu Lillian, MacLean Martha, Doppler Karen, Walsh Wendy, Fisher Bryn, Khan Azhar Z, de Alwis Dinesh P, Weitzman A, Brail Leslie H and Moore Malcolm. A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. : Investigational new drugs. 20070730.